Invention Grant
- Patent Title: Antisense oligonucleotides to treat Dystrophic Epidermolysis Bullosa
-
Application No.: US15575559Application Date: 2016-05-20
-
Publication No.: US10370660B2Publication Date: 2019-08-06
- Inventor: Elisabeth Marlene Haisma , Marko Potman , Gerardus Johannes Platenburg
- Applicant: ProQR Therapeutics II B.V.
- Applicant Address: US CA Berkeley
- Assignee: WINGS THERAPEUTICS, INC.
- Current Assignee: WINGS THERAPEUTICS, INC.
- Current Assignee Address: US CA Berkeley
- Agency: Minz Levin Cohn Ferris Glovsky and Popeo PC
- Priority: GB1508733.1 20150521; GB1516505.3 20150917
- International Application: PCT/EP2016/061495 WO 20160520
- International Announcement: WO2016/185041 WO 20161124
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/113
Abstract:
An antisense oligonucleotide capable of preventing or reducing exon 80 inclusion into a human COL7A1 mRNA, and methods for preventing or reducing exon 80 inclusion into a human COL7A1 mRNA.
Public/Granted literature
- US20180245078A1 ANTISENSE OLIGONUCLEOTIDES TO TREAT DYSTROPHIC EPIDERMOLYSIS BULLOSA Public/Granted day:2018-08-30
Information query
